Click here to jump to the main content
National Drug Policy New Zealand Home.

National Drug Policy New Zealand

Print this   Email this

Tobacco

Objectives of the Review of Smoke-free Environments Regulations 1999

The objectives of the Review of Smoke-free Environments Regulations 1999 are:

  • To ensure that New Zealand complies with the mandatory requirements of Article 11 of the Framework Convention on Tobacco Control, as a minimum.
  • To determine what warnings, messages, and other information (including the possibility of pictorial warnings) should optimally be required to be displayed on all tobacco products.
  • To review whether the use of certain terms, descriptors and markings should be regulated or prohibited on the grounds of actual or potential ability to mislead or deceive consumers.
  • To review options for reducing the harm caused by tobacco use.
The Review covers but is not limited to:
  • Examining the size and nature of health warnings on tobacco products. The FCTC states that the warnings must be a minimum of 30% of principal display areas and should be 50% or more of principal display areas.
  • Developing options for health warnings, including options for pictorial warnings.
  • Reviewing the use of terms on tobacco products that might mislead or deceive consumers. This includes Investigating people's perceptions of the terms 'light' and 'mild' in relation to tobacco products.
  • International research has shown that these terms may be misleading smokers into thinking they are smoking a safer cigarette when in fact the effects of 'light', 'mild' and 'regular' products are equally harmful.
  • Reviewing the disclosure of information to government, on tobacco constituents, the constituents of tobacco smoke and additives to tobacco products.
  • Reviewing the information on constituents of tobacco products to be on or inserted in tobacco packaging.
  • Considering the required references to nicotine / tar / CO levels and whether they provide accurate information.
  • Canvassing options for harm reduction measures including:
    • The possible development of a regime for the regulation of novel tobacco products and
    • Regulating constituents of tobacco.